INSR and Insulin resistance: Sphingolipids and S1P indirectly impact the PI3K/Akt signaling pathway by altering insulin receptor autophosphorylation and insulin receptor substrate (IRS) protein activity, which weakens insulin signaling and contributes to insulin resistance development.